Skye Bioscience SKYE
NASDAQ SKYE
$1.61 +0.02 (+1.26%)
At close: Sep 30, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Preferred Shares (2015)

Updated

Skye Bioscience (SKYE) recorded Preferred Shares of $1.36 million in Q4 2015, down 15.9% from the prior quarter.

Analysis

Skye Bioscience (SKYE) Preferred Shares (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn -
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn -
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn -
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Skye Bioscience 6.98 Mn 6.98 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 1.36 Mn
Sep 30, 2015 1.62 Mn
Jun 30, 2015 400.00
API Access

Skye Bioscience Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=SKYE&period=max&api_key=YOUR_API_KEY